We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IRHO:NASDAQIron Horse Acquisitions II Corp. Analysis

Data as of 2026-04-11 - not real-time

$9.88

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

IRHO trades at $9.88, barely above its 20‑day and 200‑day SMAs (≈9.86) and sits at the technical resistance level of $9.88, while the RSI of 58 signals a market that is not yet overbought. MACD is bullish with a positive histogram, yet the overall trend is flagged as bearish, creating a mixed technical picture. Fundamentally, the company has zero revenue, negative book value per share, an astronomically high trailing PE of 247 and a negative price‑to‑book ratio of –282, indicating severe overvaluation. Cash on hand (~$718k) exceeds debt (~$1.8k), but operating cash flow is deeply negative, and there is no dividend to speak of. Volume is rising but remains far below its 10‑day average, pointing to thin liquidity. The SPAC’s sector – shell companies – carries inherent acquisition risk, and the lack of any operating history makes the valuation largely speculative. Given the “Extreme Greed” market sentiment (fear‑greed index 87), the stock may be vulnerable to a rapid pull‑back if merger news stalls. Investors should weigh the potential upside of a successful business combination against the current overvaluation and liquidity constraints.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price at technical resistance with bearish trend flag
  • extreme overvaluation (high PE, negative PB)
  • thin trading volume increasing liquidity risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • potential merger catalyst could unlock value
  • strong cash position relative to minimal debt
  • ongoing uncertainty around acquisition target

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • no operating history or earnings to sustain valuation
  • valuation risk remains high without concrete deal
  • sector dynamics of SPACs suggest speculative upside only if deal succeeds

Key Metrics & Analysis

Financial Health

P/E Ratio247.0
P/B Ratio-282.3
Op. Cash Flow$-564417
Industry P/E17.1

Technical Analysis

TrendBearish
RSI58.4
Support$9.85
Resistance$9.88
MA 20$9.86
MA 200$9.87
MACDBullish
VolumeIncreasing
Fear & Greed Index87.09

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.00
Volatility1.96%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.